GGrantIndex
Sort

78,016 grants matching breast cancer

Prospective Studies of Diet and Cancer in the AARP Cohort

$1,575,753
Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

SLIT2 AS A NOVEL APPROACH FOR TARGETING METASTATIC BREAST CANCER

$1,574,999
Ohio State University, The · · FY2025 · Defense Health Agency

Mammary Gland as a Sensitive End Point to Effects of Endocrine Disruptors

$1,574,798
Suzanne Fenton · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCER

$1,574,247
University Of Hawaii At Manoa · R01 · FY2002 · CA

Genetic Analysis of the Breast Tumor Microenvironment

$1,574,165
Michael C Ostrowski · Ohio State University · P01 · FY2012 · CA

NRG Oncology Network Group Operations Center

$1,573,818
Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2020 · CA

Adolescent Diet, Hormones & Breast Cancer Susceptibility

$1,573,021
Joanne F Dorgan · Fox Chase Cancer Center · R01 · FY2006 · CA

Proteases in Cancer Biology and Drug Development

$1,572,052
Zena Werb · University Of California, San Francisco · P01 · FY2006 · CA

Hormone Receptors and Genes Regulating Gonadal and mammary function

$1,571,278
Maria Dufau · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

Center for Environment and Mammary Gland Development

$1,571,038
Fox Chase Cancer Center · U01 · FY2003 · ES

Family Studies

$1,570,700
Mary McMaster · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,570,521
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA

CD28-KITv CAR T cells with PD-1 dominant negative receptor

$1,570,342
Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · UG3 · FY2025 · CA

DNA Sequencing and FACS Core Facilities

$1,570,280
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

Proteases in Cancer Biology and Drug Development

$1,569,832
Zena Werb · University Of California, San Francisco · P01 · FY2007 · CA

Early Phase Clinical Cancer Prevention Consortium

$1,569,332
Dean E. Brenner · University Of Michigan At Ann Arbor · UG1 · FY2021 · CA

Antigen-targeted activation of Topo1 inhibitors via click chemistry

$1,568,070
Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2024 · CA

Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort

$1,567,792
Garnet L. Anderson · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA

A Follow-up Study for Causes of Illness in Black Women

$1,567,175
Boston University Medical Campus · R01 · FY2005 · CA

Intervention Trials in Persons at Increased Genetic Risk of Cancer

$1,567,046
Mark H Greene · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

Early Life Exposures and Subsequent Cancer Risk

$1,566,550
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies

$1,566,249
Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2022 · CA

Proteases in Cancer Biology and Drug Development

$1,565,484
University Of California San Francisco · P01 · FY2005 · CA

University of Maryland Greenebaum Cancer Center Support Grant

$1,565,163
Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2012 · CA

OVERCOMING BREAST CANCER METASTASIS TO BONE BY CXCR2 INHIBITION

$1,564,998
University Of Notre Dame Du Lac · · FY2021 · Defense Health Agency